OncoMark Ltd. is a private company centred on the development and application of biomarker panels for oncology drug development, including multiplex antibody-based assays and high-throughput tissue microarray screening.
Developer of an analytic aggregation software designed to transform regulatory compliance and customer onboarding for firms. The company's software incorporates real-time data and documents from authoritative global public data sources and private customer information to create and maintain digital risk profiles, enabling clients to gain insight into corporate, personal, and property data to help address issues such as money laundering and know-your-customer regulations.